Biosynthesis of the DNA base thymine depends on activity of the enzyme thymidylate synthase to catalyse the methylation of the uracil moiety of 29-deoxyuridine-59-monophosphate. All known thymidylate synthases rely on an active site residue of the enzyme to activate 29-deoxyuridine-59-monophosphate 1,2 . This functionality has been demonstrated for classical thymidylate synthases, including human thymidylate synthase, and is instrumental in mechanism-based inhibition of these enzymes. Here we report an example of thymidylate biosynthesis that occurs without an enzymatic nucleophile. This unusual biosynthetic pathway occurs in organisms containing the thyX gene, which codes for a flavindependent thymidylate synthase (FDTS), and is present in several human pathogens 3-5 . Our findings indicate that the putative active site nucleophile is not required for FDTS catalysis, and no alternative nucleophilic residues capable of serving this function can be identified. Instead, our findings suggest that a hydride equivalent (that is, a proton and two electrons) is transferred from the reduced flavin cofactor directly to the uracil ring, followed by an isomerization of the intermediate to form the product, 29-deoxythymidine-59monophosphate. These observations indicate a very different chemical cascade than that of classical thymidylate synthases or any other known biological methylation. The findings and chemical mechanism proposed here, together with available structural data, suggest that selective inhibition of FDTSs, with little effect on human thymine biosynthesis, should be feasible. Because several human pathogens depend on FDTS for DNA biosynthesis, its unique mechanism makes it an attractive target for antibiotic drugs.
Biosynthesis of the DNA base thymine depends on activity of the enzyme thymidylate synthase to catalyse the methylation of the uracil moiety of 29-deoxyuridine-59-monophosphate. All known thymidylate synthases rely on an active site residue of the enzyme to activate 29-deoxyuridine-59-monophosphate 1, 2 . This functionality has been demonstrated for classical thymidylate synthases, including human thymidylate synthase, and is instrumental in mechanism-based inhibition of these enzymes. Here we report an example of thymidylate biosynthesis that occurs without an enzymatic nucleophile. This unusual biosynthetic pathway occurs in organisms containing the thyX gene, which codes for a flavindependent thymidylate synthase (FDTS), and is present in several human pathogens [3] [4] [5] . Our findings indicate that the putative active site nucleophile is not required for FDTS catalysis, and no alternative nucleophilic residues capable of serving this function can be identified. Instead, our findings suggest that a hydride equivalent (that is, a proton and two electrons) is transferred from the reduced flavin cofactor directly to the uracil ring, followed by an isomerization of the intermediate to form the product, 29-deoxythymidine-59monophosphate. These observations indicate a very different chemical cascade than that of classical thymidylate synthases or any other known biological methylation. The findings and chemical mechanism proposed here, together with available structural data, suggest that selective inhibition of FDTSs, with little effect on human thymine biosynthesis, should be feasible. Because several human pathogens depend on FDTS for DNA biosynthesis, its unique mechanism makes it an attractive target for antibiotic drugs.
Classical thymidylate synthases, encoded by the thyA and TYMS genes, are present in most eukaryotes, including humans, and are frequently targeted by chemotherapeutic and antibiotic drugs. A recently discovered class of thymidylate synthases, the FDTSs 3,6,7 , is encoded by the thyX gene and has been found primarily in prokaryotes and viruses 3, 8 , including several pathogens and biological warfare agents (see http://www.cdc.gov). Several organisms, including human pathogens, rely solely on thyX for thymidylate synthesis (for example, all Rickettsia lack genes coding for DHFR, thymidylate synthase, and thymine kinase). It has recently been suggested that thyX limits chromosomal replication in these organisms 9 . FDTSs share no structure or sequence homology with classical thymidylate synthases, and thus present a promising new frontier for antibacterial/antiviral drug development [5] [6] [7] .
The catalytic mechanism of classical thymidylate synthases is presented in Fig. 1a 1, 2 . A strictly conserved active site cysteine covalently activates the uracil ring by nucleophilic Michael addition at the C6 position of 29-deoxyuridine-59-monophosphate (dUMP, Fig. 1a , step 2). The resulting enolate then attacks (step 3) the iminium form of N 5 ,N 10 -methylene-5,6,7,8-tetrahydrofolate (CH 2 H 4 folate), followed by elimination of tetrahydrofolate (H 4 folate, step 4). Finally, a hydride transfer from C6 of the H 4 folate yields the products 29-deoxythymidine-59-monophosphate (dTMP) and dihydrofolate (H 2 folate, step 5). Common drugs that target classical thymidylate synthase either covalently bind to the catalytic nucleophile (for example, 5F-dUMP) or noncovalently bind the folate binding pocket (for example, Tomudex).
It has previously been proposed that FDTSs have a chemical mechanism analogous to the classical thymidylate synthase mechanism, but with a serine residue acting as a nucleophile ( Fig. 1b, step 2 ) and a flavin cofactor providing a hydride to terminate the reaction ( Fig. 1b , step 6). This results in the production of H 4 folate rather than H 2 folate 10, 11 . The suggestion that a serine serves as the active site nucleophile in FDTS was originally based on sequence alignments of thyX genes that indicated no conserved cysteine but a strictly conserved serine. Crystal structures of FDTSs from three very different organisms 7, 12, 13 placed this conserved serine about 4 Å from the C6 position of dUMP (for example, Fig. 2a ). However, without a neighbouring general base this serine will not be deprotonated, decreasing its potential reactivity, casting doubt on this serine's putative role as a nucleophile.
Point mutation studies were performed with FDTS from Helicobacter pylori (HpFDTS), where the conserved serine residue was mutated to either alanine or cysteine (S84A and S84C). Although both mutations were found to retain activity 4 , it was assumed that an adjacent serine (Ser 85) could have rescued the activity of S84A. Abolished enzyme activity of a double mutant (S84A/S85A) supported this hypothesis. Furthermore, matrixassisted laser desorption/ionization-time of flight (MALDI-TOF) mass spectrometry analysis showed that the S84C mutant forms a covalent adduct with dTMP. These results were used to propose that Ser 84 activates dUMP ( Fig. 1b) 4, 11 .
To test this hypothesis further, we performed similar mutation studies using FDTS from Thermotoga maritima (TmFDTS). The active site of this enzyme contains a strictly conserved serine, Ser 88, and no alternative nucleophilic residues (see refs 6, 7 and Supplementary Information). Activity tests for S88A and S88C (for details see ref. 11 and Supplementary Information) indicated that both mutants were still active. Possible contamination by classical Escherichia coli thymidylate synthase was ruled out by a series of control experiments to ensure that mutant FDTS was the sole source of the observed activity (see Supplementary Information). The FDTS activity of these mutants and the lack of classical thymidylate synthase activity of S88C demonstrate that the conserved active site serine does not serve as a catalytic nucleophile in the FDTS reaction, in contrast to the mechanism proposed hitherto ( Fig. 1b ).
Crystal structures of the S88A and S88C mutants were obtained at 1.95 and 2.05 Å resolution, respectively (see data collection/refinement statistics in Supplementary Information), and their electron density is compared to that of the wild-type TmFDTS (Fig. 2 ). The electron densities for both mutants indicate minimal changes in folding and active site configuration. It is apparent from Fig. 2c that there is no covalent bond between the cysteine and dUMP in the crystal. Nevertheless, a MALDI-TOF analysis of the trypsin-digested S88C TmFDTS indicated that Cys 88 is bound to dUMP (see Supplementary Information), as previously reported for HpFDTS 4 . Even in solution, cysteine covalently binds to the C6 position of uracil 14 . These facts, together with the low activity of S88C, suggest that the observed Cys 88-dUMP complex is not part of the FDTS catalytic cascade, but rather an inhibitory dead-end complex.
A critical piece of evidence for the covalent bond between the active site cysteine in classical thymidylate synthase and dUMP is the crystal structure of a covalently bound 5-flouro-dUMP (5F-dUMP) in complex with CH 2 H 4 folate (Protein Data Bank accession 1tls, ref. 15) . In contrast to classical thymidylate synthase, FDTS does not covalently bind 5F-dUMP upon incubation with CH 2 H 4 folate, as confirmed by both MALDI-TOF analysis (see Supplementary Information) and crystal structure analysis (Protein Data Bank 1o28, ref. 7) obtained under similar conditions. Another test for similar Michael addition to the C6 of dUMP is the dehalogenation of 5-bromo-dUMP (5Br-dUMP) 2, 16 . This test resulted in no reactivity with FDTS (see Supplementary Information). We also solved the crystal structures of TmFDTS with FAD and both 5-halogenated-dUMPs (Protein Data Bank 1o27 and 1o28); the 5Br-dUMP-FAD structure for FDTS from Mycobacterium tuberculosis (Protein Data Bank 2af6) was solved by ref. 13 . These structures are nearly the same as the complex with dUMP ( Fig. 2a ) and do not support a nucleophilic attack of any enzyme residue on the C6 of dUMP. These observations emphasize the distinctions between the mechanisms of classical thymidylate synthase and FDTS, and in light of the activity of the S88A mutant, support a mechanism in which FDTS does not involve a Michael addition of an enzymatic nucleophile.
To expose the nature of the FDTS catalysed reaction we followed the flow of hydrogens along the catalytic pathway by isotopic substitution of a specific hydrogen. We have previously found that when conducting the FDTS reaction in D 2 O (50% D), deuteration of the reduced flavin leads to deuterated dTMP (using electron spray ionization mass spectrometry, ESI-MS, analysis), and that reaction with tritiated 6T-CH 2 H 4 folate yields 6T-H 4 folate 11 . These results contrast the same experiments with classical thymidylate synthases, where reactions performed in D 2 O do not incorporate deuterium into the dTMP and the labelled hydride from CH 2 H 4 folate always transfers to the dTMP 17 . In the past, we and others 4, 11 suggested that these findings support the mechanism illustrated in Fig. 1b , but the current findings contradict that mechanism and required further tests. By repeating the experiment in D 2 O (this time .99.6% D), and analysing the product (1)
Ser 88 for the classical thymidylate synthase catalysed reaction 1,2 . b, The chemical mechanism for the FDTS proposed hitherto 11 . c, The newly proposed mechanism for the FDTS that does not rely on an enzymatic nucleophile.
The conserved enzymatic nucleophile is orange, the methylene is purple, the reducing hydride from H 4 folate is green, and the hydride from FADH 2 is red. R 5 29-deoxyribose-59-phosphate; R9 5 (p-aminobenzoyl)-glutamate; R99 5 adenosine-59-pyroposphate-ribityl.
using ESI-MS, 1 H NMR and 2 H NMR, we found that at 65 uC (close to the physiological temperature of T. maritima) the product was indeed deuterated at the C7 position ( Fig. 3a, b ). However, when we performed the same experiment at 37 uC, NMR analyses indicated the formation of both 6D-dTMP (60%) and 7D-dTMP (40%) (Fig. 3c, d ). This result is quite intriguing, as no mechanism previously proposed for FDTS predicts formation of 6D-dTMP, and such a phenomenon has never been reported for any thymidylate synthase reaction.
The lack of an obvious enzymatic nucleophile and the ability to trap deuterium from D 2 O at C6 of the product demonstrate that the chemical mechanisms of FDTS and classical thymidylate synthase differ substantially. Without an enzymatic nucleophile, the FDTS catalysed reaction could proceed via Michael addition of a hydroxide ion or though participation of the flavin prosthetic group. For hydroxide to serve as a nucleophile, a water molecule must be activated by a general base in the active site (for example, the catalytic triad in hydrolytic enzymes). All crystal structures of FDTSs indicate that there is no such basic system available in the active site. Additional experiments using reduced 5-carba-5-deaza-FAD resulted in dTMP formation, excluding the possibility that the reduced N5 of FADH 2 is the nucleophile. Notably, the FDTS mechanism requires a hydrogen transfer to the C6 of the uracil moiety to explain the formation 6D-dTMP from reactions performed in D 2 O, which is inconsistent with either hydroxyl or flavin as Michael nucleophiles.
In Fig. 1c we propose a new chemical mechanism consistent with current data and previous findings 18 , wherein a hydride equivalent from the N5 of FADH 2 is transferred to C6 of dUMP ( Fig. 1c, step 1) . The resulting enolate anion nucleophilically attacks the iminium methylene of CH 2 H 4 folate, and an elimination of H5 from dUMP and H 4 folate results in a C55C7 double bond (steps 2 and 3). This exocyclic-methylene intermediate then isomerizes to form the product, dTMP (step 4). The intermediate proposed here is unique in nucleotide biochemistry, but this isomer of the thymine moiety is chemically feasible and quite stable in solution 19 . This mechanism is compatible with our previous findings 18 on the oxidative halfreaction if the equilibrium constant for the first step lies to the left. Because we have no experimental data regarding the methylene transfer and the initial activation (if not H transfer), steps 2 and 3 are proposed here as a logical path towards the product and step 1 might be preceded by other activation steps.
Because the isomerization of the putative intermediate (Fig. 1c, step 4 ) does not occur rapidly in solution 19 , the enzyme could catalyse this transformation by the two mechanisms illustrated in Fig. 4 . An enzymatic acid could catalyse this step via an addition-elimination mechanism (AEM), in which a proton is added to the C55C7 double bond and the intermediate cation loses a proton from C6 to form the product. Alternatively, the thermodynamic driving force (.6 kcal mol 21 as estimated from semi-empirical quantum mechanical calculations) could favour a 1,3-sigmatropic rearrangement (1,3-hydride shift) 20 . Supplementary Fig. 4) did not indicate such a product. Therefore, a suitable explanation is an enzyme-catalysed isomerization via a 1,3-H shift (Fig. 4 , lower path). The finding that two different isotopically labelled products are formed at 37 uC was intriguing and warranted further investigation. Thus, we performed the FDTS reactions using dUMP, with D at its C6, in an H 2 O buffer at 37 uC ( Fig. 4, experiment B ). NMR analysis of the product showed the formation of 6D-dTMP (.99%). If any 6H-dTMP was formed, it was below our detection limits (,1%). The observations for both experiments (6H-dUMP in D 2 O and 6D-dUMP in H 2 O) can be explained by the combination of normal kinetic isotope effect (KIE; H reacts faster than the heavier D) and reduced stereoselectivity at reduced temperature (37 uC). Lack of stereoselectivity at reduced temperature has already been observed during the reductive-half reaction of FDTS, which transfers both 4-(R) and 4-(S) hydride of NADPH 11 . A KIE of 10 and stereoselectivity of 87%, for example, would result in production of 60:40 C6:C7-dTMP when 6H-dUMP reacts with FDTS in D 2 O, and more than 99:1 C6:C7-dTMP produced when 6D-dUMP reacts in H 2 O (see Supplementary Information for a more detailed discussion).
The proposed hydrogen transfer to the C6 of dUMP by the flavin cofactor is further supported by the crystal structures, which show a short distance (3.4 Å ) between N5 of the flavin ring and C6 of dUMP (Fig. 2) . Such hydride transfer from FADH 2 to a uracil ring is an atypical chemistry for thymidylate synthases and nucleotide methylation in general, but is not unprecedented in enzymology. For example, dihydroorotate dehydrogenase and old yellow enzyme are other flavo-proteins that catalyse similar chemistry 21, 22 .
To the best of our knowledge, neither hydride transfer to the uracil ring nor an isomerization of such an intermediate has been reported for any thymine biosynthetic pathway or other nucleotide methylations. Notably, such a chemical mechanism is very different from that of classical thymidylate synthases, and along with structural differences, may help explain why classical thymidylate synthase inhibitors have a reduced effect on FDTSs 5 . These findings suggest that selective inhibition of FDTS should be feasible, and may further alleviate the constraint of an enzymatic nucleophile from structure-based rational drug design efforts. Rationally designed compounds could mimic the non-covalently bound intermediate or the transition states for its formation and isomerization. Such compounds may inhibit FDTS with little effect on classical thymidylate synthases and thus may serve as leads to selective antibiotics that would not interfere with human thymine biosynthesis.
METHODS SUMMARY
Purification and activity of FDTS enzymes. The FDTS from T. maritima (TM0449, GenBank accession number NP228259), and its mutants S88A and S88C, were expressed and purified as previously described 6 . The activities of these enzymes were determined using a [2-14 C]dUMP assay which is a modification of the procedure developed and described in ref. 11 . Mutant reactivity was also determined by oxidation of chemically reduced enzyme by CH 2 H 4 folate and dUMP under an atmosphere of purified Ar. Halogenated substrate derivatives. The 5Br-dUMP assay was adopted from ref. 16 . A thymidylate synthase inhibitor, 5F-dUMP, was assessed as a covalent inhibitor of FDTS by incubating it with the enzyme in the presence of CH 2 H 4 folate and sodium dithionite, followed by removal of small molecules by ultra filtration. Activities of the incubated enzymes were determined before MALDI-TOF analyses. Mass spectroscopy and NMR analyses. All MALDI-TOF and ESI-MS analyses were conducted at the High Resolution Mass Spectrometry Facility (HRMSF) of the University of Iowa. Enzymes were analysed after trypsin digestion. NMR analyses were performed at the University of Iowa NMR Central Research Facility and Medical NMR Facility using Bruker model Av-300 (for 1 H NMR measurements) and Av-800 (for 2 H NMR measurements) spectrometers. Following the flow of deuterium during the FDTS reaction in D 2 O. Experiments were performed at 65 and 37 uC using dUMP or 6D-dUMP, NADPH, CH 2 H 4 folate and enzyme in D 2 O or H 2 O under anaerobic conditions. The product dTMP was then purified using semi-preparative reverse-phase HPLC.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature. examine the hydride flow in the reaction catalysed by the thermophilic TmFDTS at reduced temperature (37 uC). Experiment A was performed in a D 2 O buffer using 6H-dUMP (that is, unlabelled dUMP). Experiment B was performed in an H 2 O buffer using 6D-dUMP (see Supplementary  Information) . Percentages below each species represent the relative quantities of product formation as indicated by 1 H and 2 H NMR.
METHODS
Materials. All materials were reagent grade and used without further purification unless specified. 29-deoxyuridine-59-monophosphate (dUMP), reduced nicotinamide adenosine dinucleotide phosphate (NADPH), 5-bromo-29-deoxyuridine (5Br-dU), 5-fluoro-29-deoxyuridine-59-monophosphate (5F-dUMP), trypsin protease, ammonium bicarbonate, tris(hydroxymethyl)aminomethane, D 2 , D 2 O, phosphocreatine and creatine kinase were purchased from Sigma. Radiolabelled [2-14 C]dUMP was obtained from Moravek Biochemicals. N 5 ,N 10 -methylene-5,6,7,8-tetrahydrofolate (CH 2 H 4 folate) was a gift from Eprova Inc. The FDTS from T. maritima (TM0449, GenBank accession number NP228259) and its mutants S88A and S88C were expressed and purified as previously described 6 . The thymidine kinase plasmid was obtained from R. Stroud's laboratory at UCSF and expressed and purified as described in ref. 23. Synthesis of 5-bromo-29-deoxyuridine-59-monophosphate (5Br-dUMP). 5Br-dUMP was synthesized by phosphorylation of 5Br-dU at 37 uC in a 100 mM Tris, 10 mM MgCl 2 buffer at pH 7.5. The reaction mixture contained 1.5 mM 5Br-dU, 5 mM ATP, 50 mg ml 21 Vacuum filtration removed the catalyst and the remaining solution was lyophilized to dryness. NMR analysis confirmed .99.5% D atom substitution of both the 5 and 6 positions of the uracil ring. A method to substitute the 5D into 5H without affecting 6D has been developed 14 ; however, such substitution was not used in the current preparation because the thymidylate synthase reaction is a substitution reaction where a methyl group replaces the 5H of dUMP to form dTMP. Because the 5H position is always replaced during the synthesis of dTMP 1,2,4 its isotopic labelling can be disregarded. Analytical methods. All analytical separations were performed on an Agilent series HPLC model 1100, equipped with online degasser, UV/Vis diode array detector and 500TR series Packard flow scintillation analyser (FSA). A Supelco reverse phase column (Discover series 250 mm 3 4.6 mm) was used starting with 100 mM KH 2 PO 4 (pH 6.0) followed by a methanol gradient as described elsewhere 11 . The enzyme active site concentration was determined by the 454 nm absorbance of bound FAD (e 5 11,300 cm 21 M 21 ). Purification methods. Separation by HPLC was performed using a semipreparative reverse phase Supelco Column (Discovery series 250 mm 3 10 mm). Mobile phase used for separation was a gradient of 100 mM KH 2 PO 4 and methanol. Eluent was collected according to the ultraviolet spectral absorbance of the purified species and then lyophilized to dryness. Protein crystallization. The protein-FAD-dUMP complex was prepared by treating 15 mg ml 21 5Br-dUMP assay. Reactions with either E. coli thymidylate synthase or TmFDTS were performed in a 200 mM Tris buffer at pH 8.0, containing 100 mM 5Br-dUMP, 5 mM sodium dithionite, and 5 mM b-mercaptoethanol. Enzyme was added to the reaction mixture which was then incubated at 37 uC for 3 h. Product conversion was determined by HPLC-UV/Vis analysis of the reaction mixtures by following both 256 and 280 nm absorptions for dUMP and 5Br-dUMP, respectively. Oxidative half-reaction of S88A. A solution of oxidized S88A (20 mM) and dUMP (1 mM) was made anaerobic in a sealed cuvette by successive cycles of evacuation and equilibration with an atmosphere of purified Ar. The oxidized enzyme was titrated spectrophotometrically to complete reduction with a solution of dithionite. CH 2 H 4 folate was added anaerobically from a side arm to initiate the reaction (25 uC). The absorbance spectrum of oxidized enzyme returned before the first scan, indicating a rapid reaction of the mutant enzyme. Protein digestion. All enzyme digestion reactions were performed in 100 mM ammonium bicarbonate buffer adjusted to pH 8.0 at 37 uC. Enzyme solutions were diluted to 1 mM protein concentration followed by addition of trypsin to a final concentration of 10 ng ml 21 . All digestions were allowed to incubate for 3 h at 37 uC and stored at 220 uC before MALDI-TOF mass spectrometry analysis. Assessment of 5F-dUMP as a covalent inhibitor of FDTS. These experiments were performed at 37 uC in 200 mM Tris buffer at pH 8.00. Both wild-type FDTS and S88A (11 mM active site concentration) were incubated for 30 min in the presence of 50 mM 5F-dUMP, 200 mM CH 2 H 4 folate and 5 mM sodium dithionite. After incubation, activities of the enzymes were determined using the standard activity assay conditions (except with a residual 5 mM 5F-dUMP). Samples of native and trypsin-digested enzymes were prepared for MALDI-TOF MS analysis. The remaining enzyme solutions were exchanged with 40 ml of Tris buffer at 4 uC, and concentrated by centrifugal filtration (using a Millipore 10,000 MWCO filtration device) to 11 mM active site concentration. Once concentrated, the activity of both FDTS and S88A was determined using the standard activity assay conditions. As described in the report, no covalent adduct of 5F-dUMP to enzyme was identified and both enzymes recovered 100% activity after the removal of the 5F-dUMP from the reaction mixture. 
